Abstract
Investigations in animals have suggested that conjugation of paracetamol may be reduced in malaria. We have measured plasma concentrations and the urinary excretion of paracetamol and its phase II metabolites in eight Thai patients during uncomplicated falciparum malaria and in convalescence, following a 1000 mg single oral dose.
The apparent oral clearance (Malaria, 3.6; Convalescence, 3.9; ml·min−1·kg−1), the elimination half-life (Malaria, 3.8; Convalescence, 3.7 h) and apparent volume of distribution (Malaria, 1.2; Convalescence, 1.2; l·kg−1) of paracetamol were similar during malaria and convalescence. In addition, the urinary excretion of paracetamol and its major phase II metabolites and their formation clearances from paracetamol were not significantly different between the two study phases.
These data show that clinical malaria infection has no effect on the conjugation of paracetamol in man.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Emudianughe TS, Bickel QD, Taylor MG, Andrews B (1985) Effect of Plasmodium berghei infection on benzoic acid metabolism in mice. Experientia 41: 1407–1409
Mansor SM, Edwards G, Roberts PJ, Ward SA (1991) The effect of malaria infection on paracetamol disposition in the rat. Biochem Pharmacol 41: 1707–1711
Murdoch RT, Ghabrial H, Smallwood RA, Morgan DJ (1992) Effect of malaria on phenol conjugation pathways in perfused rat liver. Biochem Pharmacol 43: 1229–1234
Murdoch RT, Ghabrial H, Mihaly GW, Morgan DJ, Smallwood RA (1991) Malaria infection impairs glucuronidation and biliary excretion by the isolated perfused rat liver. Xenobiotica 21: 1571–1582
Ismail S, Back DJ, Edwards G (1992) The effect of malaria infection on 3′azido-3′deoxythymidine and paracetamol glucuronidation in rat liver microsomes. Biochem Pharmacol 44: 1879–1882
Ismail S, Kokwaro GO, Back DJ, Edwards G (1994) Effect of malaria infection on the pharmacokinetics of paracetamol in the rat. Xenobiotica 24: 527–533
Prescott LF (1980) Kinetics and metabolism of paracetamol and phenacetin. Br J Clin Pharmacol 10: 291S-298S
Prescott LF (1969) The metabolism of phenacetin in patients with renal disease. Clin Pharmacol Ther 10: 383–394
Forfar JC, Pottage A, Toft AD, Irvine WJ, Clements JA, Prescott LF (1980) Paracetamol pharmacokinetics in thyroid disease. Eur J Clin Pharmacol 18: 269–273
Douglas AP, Savage RL, Rawlins MD (1978) Paracetamol (acetaminophen) kinetics in patients with Gilbert's syndrome. Eur J Clin Pharmacol 13: 209–212
Forrest JAH, Adriaenssens PI, Finlayson NDC, Prescott LF (1979) Paracetamol metabolism in chronic liver disease. Eur J Clin Pharmacol 15: 427–431
Trenholme GM, Williams RL, Rieckmann KH, Frischer H, Carson PE (1976) Quinine disposition during malaria and during induced fever. Clin Pharmacol Ther 19: 459–467
White NJ, Looareesuwan S, Warrell DA, Bunnag D, Harinasuta T (1982) Quinine pharmacokinetics and toxicity in cerebral and uncomplicated falciparum malaria. Am J Med 73: 564–572
Juma FD, Ogeto JO (1989) Mefloquine disposition in normals and in patients with severe Plasmodium falciparum malaria. Eur J Drug Metab Pharmacokinet 14: 15–17
Boudreau EF, Fleckenstein L, Pang MP, Childs GE, Schroeder AC, Ratnaratorn B, Phintuyothin P (1990) Mefloquine kinetics in cured and recrudescent patients with acute falciparum malaria. Clin Pharmacol Ther 48: 399–409
Edwards G, McGrath CS, Ward SA, Supanaranond W, Pukrittayakamee S, Davis TME, White NJ (1993) Interactions among primaquine, malaria infection and other antimalarials in Thai subjects. Br J Clin Pharmacol 35: 193–198
Howie D, Adriaenssens PI, Prescott LF (1977) Paracetamol metabolism following overdosage: application of HPLC. J Pharm Pharmacol 29: 235–237
Back DJ, Tjia JF (1987) Single dose primaquine has no effect on paracetamol clearance. Eur J Clin Pharmacol 32: 203–205
Looareesuwan S, White NJ, Warrell DA, Forgo I, Dubach UG, Ranalder UB, Schwartz DE (1987) Studies of mefloquine bioavailability and kinetics using a stable isotope technique: a comparison of Thai patients with falciparum malaria and healthy Caucasian volunteers. Br J Clin Pharmacol 24: 37–42
Prescott LF, Yoovathaworn K, Makarananda K, Saivises R, Sriwatanakul K (1993) Impaired absorption of paracetamol in vegetarians. Br J Clin Pharmacol 36: 237–240
Critchley JAJH, Nimmo GR, Gregson CA, Woolhouse NM, Prescott LF (1986) Intersubject and ethnic differences in paracetamol metabolism. Br J Clin Pharmacol 22: 649–657
Mercado TI, Von Brand T (1954) Glycogen studies on white rats infected with Plasmodium berghei. Exp Parasitol 3: 259–266
Marsh K (1992) Malaria — a neglected disease? Parasitology 104 [Suppl]: S53-S69
White NJ (1994) Artemisinin: current status. Trans R Soc Trop Med Hyg 88 [Suppl 1]: 3–4
Rosen S, Roycroft DW, Hano JE, Barry KG (1967) The liver in malaria. Arch Pathol 83: 271–277
Fischer RG, Booth BH, Mitchell DQ, Kibbe AM (1982) Influence of trivalent influenza vaccine on serum theophylline levels. Can Med Assoc J 126: 1312–1314
Kramer P, Mc Clain CJ (1981) Depression of aminopyrine metabolism by influenza vaccination. N Engl J Med 305: 1262–1264
Scavone JM, Blyden GT, Greenblatt DJ (1989) Lack of an effect of influenza vaccine on the pharmacokinetics of of antipyrine, alprozolam, paracetamol (acetaminophen) and lorazepam. Clin Pharmacokinet 16: 180–185
Na Bangchang K, Limpaibul L, Thanavibul P, Tan-Ariya P, Karbwang J (1994) The pharmacokinetics of chloroquine in healthy Thai subjects and patients with Plasmodium vivax malaria. Br J Clin Pharmacol 38: 278–281
Wilairatana P, Looareesuwan S, Vanijanonta S, Charoenlarp P, Wittayalertpanya S (1994) Hepatic metabolism in severe falciparum malaria: caffeine clearance study. Ann Trop Med Parasitol 88: 13–20
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ismail, S., Back, D.J., Edwards, G. et al. Paracetamol disposition in Thai patients during and after treatment of falciparum malaria. Eur J Clin Pharmacol 48, 65–69 (1995). https://doi.org/10.1007/BF00202175
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00202175